By removing senescent, chronically activated, or stressed immune cells at sites of inflammation, TRAIL/DRs regulate innate and adaptive immune responses by terminating the response and by limiting thereby tissue damage and the risk of autoimmunity. The gene discussed is TNFSF10; the disease is Autoimmunity.